Year |
Citation |
Score |
2020 |
Lee PY, Day-Lewis M, Henderson LA, Friedman K, Lo J, Roberts JE, Lo MS, Platt CD, Chou J, Hoyt KJ, Baker AL, Banzon T, Chang MH, Cohen E, de Ferranti S, et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. The Journal of Clinical Investigation. PMID 32701511 DOI: 10.1172/Jci141113 |
0.328 |
|
2020 |
Henderson LA, Hoyt KJ, Lee PY, Rao DA, Jonsson AH, Nguyen JP, Rutherford K, Julé AM, Charbonnier LM, Case S, Chang MH, Cohen EM, Dedeoglu F, Fuhlbrigge RC, Halyabar O, ... ... Lo MS, et al. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. Jci Insight. 5. PMID 32213704 DOI: 10.1172/Jci.Insight.132508 |
0.347 |
|
2020 |
Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clinical Immunology (Orlando, Fla.). 214: 108385. PMID 32173601 DOI: 10.1016/J.Clim.2020.108385 |
0.452 |
|
2019 |
Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, ... Lo MS, et al. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. PMID 31707357 DOI: 10.1136/Annrheumdis-2019-216030 |
0.307 |
|
2018 |
Lo MS. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus. Frontiers in Immunology. 9: 1278. PMID 29922296 DOI: 10.3389/Fimmu.2018.01278 |
0.337 |
|
2017 |
Lo MS, Tsokos GC. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy. Current Opinion in Rheumatology. PMID 29206660 DOI: 10.1097/Bor.0000000000000474 |
0.322 |
|
2017 |
Lo MS, Newburger JW. Role of intravenous immunoglobulin in the treatment of Kawasaki disease. International Journal of Rheumatic Diseases. PMID 29205910 DOI: 10.1111/1756-185X.13220 |
0.334 |
|
2016 |
Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nature Reviews. Rheumatology. 12: 716-730. PMID 27872476 DOI: 10.1038/Nrrheum.2016.186 |
0.346 |
|
2015 |
Walter JE, Lo MS, Kis-Toth K, Tirosh I, Frugoni F, Lee YN, Csomos K, Chen K, Pillai S, Dunham J, Tsokos GC, Luning Prak ET, Notarangelo LD. Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. The Journal of Allergy and Clinical Immunology. 135: 272-3. PMID 25312763 DOI: 10.1016/J.Jaci.2014.07.063 |
0.352 |
|
2013 |
Lo MS, Zurakowski D, Son MB, Sundel RP. Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. Pediatric Rheumatology Online Journal. 11: 42. PMID 24180594 DOI: 10.1186/1546-0096-11-42 |
0.339 |
|
2013 |
Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatric Transplantation. 17: 133-43. PMID 23228170 DOI: 10.1111/Petr.12022 |
0.316 |
|
2012 |
Moulton VR, Lo MS, Tsokos GC. Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus. Methods in Molecular Biology (Clifton, N.J.). 900: 25-60. PMID 22933064 DOI: 10.1007/978-1-60761-720-4_3 |
0.313 |
|
2012 |
Lo MS, Tsokos GC. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Annals of the New York Academy of Sciences. 1247: 138-52. PMID 22236448 DOI: 10.1111/J.1749-6632.2011.06263.X |
0.312 |
|
2012 |
Lo MS, Sundel RP. Hypergammaglobulinemia in the pediatric population Pediatric Rheumatology. 10. DOI: 10.1186/1546-0096-10-S1-A111 |
0.301 |
|
2005 |
Holtzman MJ, Tyner JW, Kim EY, Lo MS, Patel AC, Shornick LP, Agapov E, Zhang Y. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2: 132-40. PMID 16113481 DOI: 10.1513/pats.200502-015AW |
0.671 |
|
2005 |
Zhang Y, Takami K, Lo MS, Huang G, Yu Q, Roswit WT, Holtzman MJ. Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. The Journal of Biological Chemistry. 280: 34306-15. PMID 16107341 DOI: 10.1074/Jbc.M503263200 |
0.5 |
|
2005 |
Holtzman MJ, Kim EY, Lo MS, Tyner JW, Shornick LP, Sumino KC, Zhang Y. Defining and adjusting divergent host responses to viral infection. Immunologic Research. 32: 123-41. PMID 16106064 DOI: 10.1385/Ir:32:1-3:123 |
0.668 |
|
2005 |
Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. Journal of Virology. 79: 9315-9. PMID 15994826 DOI: 10.1128/Jvi.79.14.9315-9319.2005 |
0.545 |
|
2002 |
Holtzman MJ, Morton JD, Shornick LP, Tyner JW, O'Sullivan MP, Antao A, Lo M, Castro M, Walter MJ. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiological Reviews. 82: 19-46. PMID 11773608 DOI: 10.1152/Physrev.00020.2001 |
0.648 |
|
1999 |
Lo M, Bloom ML, Imada K, Berg M, Bollenbacher JM, Bloom ET, Kelsall BL, Leonard WJ. Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach Blood. 94: 3027-3036. DOI: 10.1182/Blood.V94.9.3027 |
0.345 |
|
Show low-probability matches. |